Arxis, an aerospace and defense manufacturer based in Bloomfield, Connecticut, has received positive attention from Wall Street following its initial public offering (IPO). The company's stock rose over 38% on its Nasdaq debut on April 16, although it has since decreased by 9%, remaining above its IPO price of $28.
Analysts from major banks have initiated coverage, indicating further potential for growth. Goldman Sachs, which led the IPO, has assigned a buy rating with a price target of $53, suggesting a nearly 51% increase from the stock's closing price on Friday.
Analyst Noah Poponak highlighted Arxis's aggressive acquisition strategy, noting that the company has completed 32 acquisitions since 2019, averaging more than five per year, which positions it favorably within the aerospace and defense sector. He emphasized that this model could generate significant value, especially as military spending increases.
Morgan Stanley, another lead manager for the IPO, also issued a buy rating with a price target of $44, indicating a potential 25% rise from the recent closing price. Analyst Kristine Liwag pointed out that Arxis possesses a "durable moat," which enhances its pricing power and profit margins.
She further noted that the company's diverse product portfolio allows it to capitalize on positive trends across various markets, including defense, commercial aerospace, and specialized industrial technology, while minimizing risks associated with specific platforms